Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival

Anya N A Milne, R. Carvalho, M. Jansen, E. K. Kranenbarg, C. J H Van De Velde, F. M. Morsink, A. R. Musler, M. A J Weterman, G. J A Offerhaus

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Post-translational cleavage of full-length cyclin E from the N-terminus can produce low molecular weight (LMW) isoforms of cyclin E containing the C-terminus only. Aim: To assess their presence in early-onset gastric cancer (EOGC), stump cancers and conventional gastric cancers and ascertain how they influence survival in EOGC. Methods: The expression of full-length and LMW isoforms of cyclin E in 330 gastric cancers, including early-onset gastric cancer (EOGC), stump cancer and conventional gastric cancer (>45 years old) was compared using antibodies targeted to the N- and C-terminals. Results: LMW isoforms were found in 35% of EOGCs, compared to 8% of conventional gastric cancers and 4% of stump cancers; their presence was visualised in cell lines using western blot analysis. In addition, C-terminal staining was a positive predictor of survival in EOGC. In contrast, no correlation with survival was found with the N-terminal antibody which detects only full-length cyclin E. Conclusion: EOGCs have a unique molecular phenotype and LMW isoforms of cyclin E may independently influence survival in EOGC.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalJournal of Clinical Pathology
Volume61
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival'. Together they form a unique fingerprint.

Cite this